Related Experiment Video
Updated: Aug 15, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Janus kinase inhibitors alter NK cell phenotypes and inhibit their antitumour capacity
Loïc Meudec1,2, Pauline Richebé2, Juliette Pascaud1
1Center for Immunology of Viral Infections and Autoimmune Diseases, INSERM UMR 1184, Université Paris-Saclay, Le Kremlin Bicêtre, Paris, France.
Objective:
Janus kinase inhibitors (JAKi) are efficacious in RA but concerns regarding the risk of cancer associated with their exposure have recently emerged. Given the role of NK cells in antitumour response, we investigated the impact of JAKi [tofacitinib (TOFA), baricitinib (BARI), upadacitinib (UPA) and filgotinib (FIL)] on NK cells.
Methods:
We first performed an ex vivo phenotype of NK cells in RA patients treated with TOFA, BARI or MTX. We next phenotyped sorted NK cells from healthy donors cultured with four JAKi or dimethyl sulphoxide (DMSO) at three concentrations, including the licensed dose (therapeutic concentration). Third, we assessed NK cell function using anti-NKp30 cross-linking and co-cultures with two different tumour cell lines: A549 and SU-DHL-4.
Results:
Twenty-eight RA patients were included. Patients treated with TOFA had reduced expression of CD69 on NK cells compared with MTX (P < 0.05). We confirmed in vitro the negative impact of JAKi on NK cell maturation (CD57), activation (CD69) and activating receptor (NKp30), these latter two being specifically altered with TOFA and UPA. When NK cells were stimulated by NKp30, we observed reduced CD107a (P < 0.01) and IFN-γ/TNF expression (P < 0.05) with TOFA. Lastly, NK cells exposed to TOFA showed reduced CD107a (P < 0.05) and altered cytotoxicity (P < 0.05) when co-cultured with the two cell lines.
Conclusion:
JAKi have a phenotypic and functional impact on NK cell activation and impair their antitumour activity, with a variable impact depending on the JAKi. It remains an open question whether this mechanism can explain the increased tumour risk observed with TOFA.
Insights
Janus kinase inhibitors (JAKi) impact natural killer (NK) cell function and antitumor activity. This study reveals that JAKi alter NK cell activation and cytotoxicity, raising questions about their role in cancer risk.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Janus kinase inhibitors (JAKi) are effective for rheumatoid arthritis (RA).
- Concerns exist regarding cancer risk associated with JAKi use.
- Natural killer (NK) cells play a crucial role in antitumor responses.
Purpose of the Study:
- To investigate the impact of JAK inhibitors on NK cells in rheumatoid arthritis patients.
- To assess the effects of specific JAK inhibitors (tofacitinib, baricitinib, upadacitinib, filgotinib) on NK cell phenotype and function.
Main Methods:
- Ex vivo phenotyping of NK cells from RA patients treated with JAKi or methotrexate (MTX).
- In vitro culture of NK cells from healthy donors with JAKi or DMSO.
- Assessment of NK cell function including activation markers, cytokine production, and cytotoxicity against tumor cell lines.
Main Results:
- JAKi treatment, particularly tofacitinib (TOFA) and upadacitinib (UPA), reduced NK cell activation markers (CD69, NKp30).
- Tofacitinib impaired NK cell degranulation (CD107a) and cytokine production (IFN-γ/TNF) upon stimulation.
- NK cells exposed to tofacitinib exhibited reduced cytotoxicity against A549 and SU-DHL-4 tumor cell lines.
Conclusions:
- JAK inhibitors have a significant impact on NK cell phenotype and function.
- These drugs impair NK cell antitumor activity, with varying effects among different JAKi.
- The observed effects on NK cells warrant further investigation into their contribution to the increased tumor risk associated with JAKi, especially tofacitinib.
Related Concept Videos
The JAK-STAT Signaling Pathway
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Inhibition of Cdk Activity
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

